Dysphagia: Evaluation and treatment

Gastroenterology Clinics of North America

Volumn 32, Issue 2, 2003, Pages 553-575

  Lind, Christopher D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BARIUM; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; NITRATE; PROTON PUMP INHIBITOR; SCOPOLAMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTIREFLUX OPERATION; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DISEASE COURSE; DRUG SAFETY; DYSPHAGIA; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; FLUOROSCOPY; HUMAN; HYPERSALIVATION; LARYNGOSCOPY; MYOTOMY; NEUROMUSCULAR DISEASE; OROPHARYNX; PATHOGENESIS; RADIODIAGNOSIS; REVIEW; SURGICAL RISK; SWALLOWING; TRACHEOTOMY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038387798     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00024-4     Document Type: Review

References (99)

1. Castell DO, Donner MW. Evaluation of dysphagia: a careful history is crucial. Dysphagia 1987;2:65-71.
2. Richter JE. Practical approach to the diagnosis and treatment of esophageal dysphagia. Compr Ther 1998;24:446-53.
3. Richter JE. Heartburn, dysphagia, odynophagia, and other esophageal symptoms. In: Sleisinger MH, Fordtran JS, editors. Gastrointestinal disease: pathophysiology, diagnosis and management. 5th edition. Philadelphia: WB Saunders; 1993. p. 331-40.
4. Cook IA, Kahrilas PJ. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology 1999;116:455-78.
5. Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50-70 year old men and women in an urban population. Dysphagia 1991;6:187-92.
6. Talley NJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
7. Siebens H, Trupe E, Siebens A, et al. Correlates and consequences of eating dependency in the institutionalized elderly. J Am Geriatr Soc 1986;34:192-8.
8. Croghan JE, Burke EM, Caplan S. Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy. Dysphagia 1994;9:141-6.
9. Diamant NE. Physiology of the esophagus. In: Sleisinger MH, Fordtran JS, editors. Gastrointestinal disease: pathophysiology, diagnosis and management. 5th edition. Philadelphia: WB Saunders; 1993. p. 319-30.
10. Feldman RS, Kapur KK, Alman JE, et al. Aging and mastications: changes in performance and in the swallowing threshold with natural dentition. J Am Geriatr Soc 1980;28:97-103.
11. Shaker R, Staff D. Esophageal disorders in the elderly. Gastroenterol Clin North Am 2001;30:335-61.
12. Kahrilas PJ, Dodds WJ, Hogan WJ. Effects of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1986;91:987.
13. Ren J, Shaker R, Medda B, et al. Effect of aging on the secondary esophageal peristalsis: presbyesophagus revisited. Am J Physiol 1995;268:G772-9.
14. Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999;117:233-54.
15. Wilcox SM, Alexander LN, Clark WS. Localization of an obstructing esophageal lesion. Is the patient accurate? Dig Dis Sci 1995;40:2192-6.
16. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology 1994;106:509-32.
17. Maddern JG, Horowitz M, Gamieson GG, et al. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 1984;87:922-6.
18. American Gastroenterology Association. American gastroenterological association medical position statement on management of oropharyngeal dysphagia. Gastroenterology 1999;116:452-4.
19. Logemann JA. Evaluation and treatment of swallowing disorders. San Diego: College Hill; 1983.
20. Martin-Harris B, Logemann JA, McMahon S, et al. Clinical utility of the modified barium swallow. Dysphagia 2000;15:136-41.
21. Langmore SE, Schatz K, Olsen N. Endoscopic and videofluoroscopic evaluations of swallowing and aspiration. Ann Otol Rhinol Laryngol 1991;100:678-81.
22. Aviv JE, Kaplan ST, Thomson JE, et al. The safety of flexible endoscopic evaluation of swallowing with sensory testing (FEESST): an analysis of 500 consecutive evaluations. Dysphagia 2000;15:39-44.
23. Ertekin C, Aydogdu I, Yuceyar N, et al. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalogr Clin Neurophysiol 1998;109:331-40.
24. Lieberman DA, De Garmo PL, Fleischer DE, et al. Patterns of endoscopy use in the United States. Gastroenterology 2000;118:619-24.
25. Ott DJ, Gelfand DW, Wu WC, et al. Radiologic evaluation of dysphagia. JAMA 1986;256:2718-21.
26. Ott DJ, Kelley TF, Chen MYM, et al. Evaluation of the esophagus with a marshmallow bolus: clarifying the causes of dysphagia. Gastrointest Radiol 1991;16:1-4.
27. Ott DJ, Richter JE, Chen YM, et al. Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol 1987;149:307-11.
28. Parkman HP, Maurer AH, Caroline DF, et al. Optimal evaluation of patients with non-obstructive esophageal dysphagia. Manometry scintigraphy, or video-esophagography? Dig Dis Sci 1996;41:1355-68.
29. Ott DJ. Radiographic techniques and efficacy in evaluating esophageal dysphagia. Dysphagia 1990;5:123-203.
30. Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology 1994;107:1865-84.
31. Gambitta P, Indriolo R, Grosso C, et al. Role of oesophageal manometry in clinical practice. Dis Esophagus 1999;12:41-6.
32. Meshkinpour H, Glick ME, Sanchez P, et al. Esophageal manometry: a benefit and cost analysis. Dig Dis Sci 1982;27:772-5.
33. Johnston PW, Johnston BT, Collins BJ, et al. Audit of the role of oesophageal manometry in clinical practice. Gut 1993;34:1158-61.
34. Katz PO, Dalton CB, Richter J, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Ann Intern Med 1987;106:593-7.
35. Leite L. Ineffective esophageal motility (IEM) the primary finding in patients with non-specific esophageal motility disorder. Dig Dis Sci 1997;42:1859-65.
36. Lindgren S. Endoscopic dilatation and surgical myectomy of symptomatic cervical esophageal webs. Dysphagia 1991;6:235-8.
37. Hatlebakk JG, Castell JA, Spiegel J, et al. Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction: manometric and symptomatic response. Dis Esophagus 1998;11:254-9.
38. Mason RJ, Bremner CG, DeMeester TR, et al. Pharyngeal swallowing disorders: selection for and outcome of myotomy. Ann Surg 1998;228:598-608.
39. Curtis DJ, Cruess DF, Berg T. The cricopharyngeal muscle: a video recording review. Am J Radiol 1984;142:497-500.
40. Ekberg O. Cricopharyngeal bar: myth and reality. Abdom Imaging 1995;20:179-81.
41. Cruse JP, Edwards DAW, Smith JF, et al. The pathology of cricopharyngeal dysphagia. Histopathology 1979;3:223-32.
42. Kodama M, Sawada H, Udaka F, et al. Dysphagia caused by an anterior cervical osteophyte: case report. Neuroradiology 1995;37:58-9.
43. Curtis DJ, Cruess DF, Crain M, et al. Lateral pharyngeal outpouchings: a comparison of dysphagic and asymptomatic patients. Dysphagia 1988;2:156-61.
44. Elmstahl S, Bulow M, Ekberg O. Treatment of dysphagia improves nutritional conditions in acute stroke. Dysphagia 1999;14:61-6.
45. Neuman S, Bartolome G, Buchholz D, et al. Swallowing therapy of neurologic patients: correlation of outcome with pretreatment variables and therapeutic methods. Dysphagia 1995;10:1-5.
46. Rudberg MA, Egleston BL, Grant MD, et al. Effectiveness of feeding tubes in nursing home residents with swallowing disorders. Journal of Parenteral and Enteral Nutrition 2000;24:97-102.
47. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989;39:1309-14.
48. Kluin KJ, Bromberg MB, Feldman EL, et al. Dysphagia in elderly men with myasthenia gravis. J Neurol Sci 1996;138:49-52.
49. Dalakas MC, Sonies B, Dambrosia J, et al. Treatment of inclusion-body myositis with IVIg: a double-blind placebo-controlled study. Neurology 1997;48:712-6.
50. Talmi YP, Finkelstein Y, Zohar Y. Reduction of salivary flow with transdermal scopolamine: a four year experience. Otolaryngol Head Neck Surg 1990;103: 615-618.
51. Ellis FH, Crozier RE. Cervical esophageal dysphagia: indications for an results of cricopharyngeal myotomy. Ann Surg 1981;194:279-89.
52. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional GI disorders; prevalence, sociodemography and health impact. Dig Dis Sci 1993;38:1569-80.
53. Marks RD, Shukla M. Diagnosis and management of peptic esophageal strictures. Gastroenterologist 1996;4:223-37.
54. Dakkak M, Hoare RC, Maslin SC, et al. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia. Gut 1993;34:152-5.
55. Tulman AB, Boyce HW. Complications of esophageal dilation and guidelines for their prevention. Gastrointest Endosc 1981;27:229-34.
56. Kozarek RA, Patterson DJ, Ball TJ, et al. Esophageal dilation can be done safely using selective fluoroscopy and single dilating sessions. J Clin Gastroenterol 1995;20:184-8.
57. Spechler SJ. AGA medical position statement on treatment of patients with dysphagia caused by benign disorders of the esophagus. Gastroenterology 1999;117:229-32.
58. Scolapio JS, Pasha TM, Gostout CJ, et al. A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings. Gastrointest Endosc 1999;50:13-7.
59. Chotiprasidhi P, Minocha A. Effectiveness of single dilation with Maloney dilator versus endoscopic rupture of Schatzki's ring using biopsy forceps. Dig Dis Sci 2000;45:281-4.
60. Eckardt VF, Kanzier G, Willems D. Single dilation of symptomatic Schatzki rings: a prospective evaluation of its effectiveness. Dig Dis Sci 1992;37:577-82.
61. Wo JM, Trus TL, Richardson WS, et al. Evaluation and management of post-fundoplication dysphagia. Am J Gastroenterol 1996;91:2318-22.
62. Pfau PR, Ginsberg GG, Lew RJ, et al. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 2000;95:2813-5.
63. Gevers AM, Macken E, Hiele M, et al. A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula. Gastrointest Endosc 1998;48:383-8.
64. Colon VJ, Young MA, Ramirez FC, et al. The short and long term efficacy of empiric esophageal dilation in patients with nonobstructive dysphagia: a prospective, randomized study. Am J Gastroenterol 2000;95:910-3.
65. Marshall JB, Chowdhury TA. Does empiric esophageal dilation benefit dysphagia when endoscopy is normal? Dig Dis Sci 1996;41:1099-101.
66. Eckardt VF, Staut B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999;116:1300-4.
67. Holloway RH, Dodds WJ, Helm JF, et al. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986;90:924-9.
68. Kahrilas PJ, Kishk SM, Helm JF, et al. Comparison of pseudoachalasia and achalasia. Am J Med 1987;82:439-46.
69. Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology 1982;83: 963-9.
70. Triadafilopoulos G, Aaronson M, Sackel S, et al. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil and placebo. Dig Dis Sci 1991;36:260-7.
71. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long term outcome and predictors of response. Gastroenterology 1996;110:1410-5.
72. Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998;27:21-35.
73. Csendes A, Braghetto I, Henriquez A, et al. Late results of a prospective randomized study comparing forceful dilation and esophagomyotomy in patients with achalasia. Gut 1989;30:299-304.
74. Ellis FH, Watkins E, Heatley GJ. Ten to 20 year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg 1992;6:86-90.
75. Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci 1993;38:75-85.
76. Spiess AE, Kahrilas PJ. Treating achalasia: from whalebone to laparoscope. JAMA 1998;280:638-42.
77. Eckardt VF, Algnherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992;103:1732-8.
78. Katz PO, Gilbert J, Castell DO. Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci 1998;43:1973-7.
79. Borotto E, Gaudric M, Danel B, et al. Risk factors of oesophageal perforation during pneumatic dilatation for achalasia. Gut 1996;39:9-12.
80. Nair LA, Reynolds JC, Parkman HP, et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm: analysis of risk factors, early clinical characteristics, and outcome. Dig Dis Sci 1993;38:1893-904.
81. Little AG, Soriano A, Ferguson MK, et al. Surgical treatment of achalasia: results with esophagomyotomy and Belsey repair. Ann Thorac Surg 1988;45:489-94.
82. Pai GP, Ellison RG, Rubin JW, et al. Two decades of experience with modified Heller's myotomy for achalasia. Ann Thorac Surg 1984;38:201-6.
83. Hunter JG, Trus TL, Branum GD, et al. Laparoscopic Heller myotomy and fundoplication for achalasia. Ann Surg 1997;225:655-64.
84. Abid S, Champion G, Richter J, et al. Treatment of achalasia: the best of both worlds. Am J Gastroenterol 1994;89:979-85.
85. Anselmino M, Perdikis G, Hinder RA, et al. Heller myotomy is superior to dilatation for the treatment of early achalasia: the best of both worlds. Am J Gastroenterol 1994;89:979-85.
86. Felix VN, Cecconello I, Zilberstein B, et al. Achalasia: a prospective study comparing the results of dilation and myotomy. Hepatogastroenterology 1998;45:97-108.
87. Mellow M. Symptomatic diffuse esophageal spasm: manometric follow-up and response to cholinergic stimulation and cholinesterase inhibition. Gastroenterology 1977;73:237.
88. Benjamin SB, Castell DO. The "nutcracker esophagus" and the spectrum of esophageal motor disorders. Current Concepts in Gastroenterology 1980;5:3.
89. Pandolfino JE, Howden CW, Kahrilas PJ. Motility-modifying agents and management of disorders of gastrointestinal motility. Gastroenterology 2000;118:S32-47.
90. Richter JE, Dalton CB, Bradley LA, et al. Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987;93:21-8.
91. Clouse RE, Lustman PH, Eckert TC, et al. Low dose trazodone for symptomatic patients with esophageal contraction abnormalities. Gastroenterology 1987;92:1027-36.
92. Jacob P, Kahrilas PJ, Vanagunas A. Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci 1990;35:939-42.
93. Clouse RE, Richter JE, Heading RC, et al. Functional dysphagia. In: Drossman D, Corazziari E, Talley N, et al, editors. Rome II, the functional gastrointestinal disorders. 2nd edition. McLean, VA: Dgjon Associates; 2000. p. 279-83.
94. Howard PJ, Maher L, Pryde A, et al. Esophageal motor patterns during episodes of dysphagia for solids. J Gastrointest Motil 1991;3:123-30.
95. Deschner WK, Maher KA, Cattau EL Jr., et al. Manometric responses to balloon distention in patients with nonobstructive dysphagia. Gastroenterology 1989;97:1181-5.
96. Gorelick AB, Koshy SS, Hooper FG, et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 1998;275:G460-6.
97. Peghini PI, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998;42:807-13.
98. Winters C, Artnak EJ, Banjamin B, et al. Esophageal bougienage in symptomatic patients with the nutcracker esophagus. JAMA 1984;252:363-6.
99. Ebert EC, Ouyang A, Wright SH, et al. Pneumatic dilatation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci 1983;28:481-5.